Skip to content
TrialScanner

NCT05275439

Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AML

Phase 1TerminatedSTTKLead

Registry record

Lead sponsor
Shattuck Labs, Inc.
Conditions
Acute Myeloid Leukemia; Myelodysplastic Syndromes
Primary completion
Feb 6, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05275439 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.